Insmed
INSM
#730
Rank
โ‚ฌ28.22 B
Marketcap
132,34ย โ‚ฌ
Share price
-0.60%
Change (1 day)
77.09%
Change (1 year)

Market capitalization of Insmed (INSM)

Market cap: โ‚ฌ28.22 Billion

As of February 2026 Insmed has a market cap of โ‚ฌ28.22 Billion. This makes Insmed the world's 730th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Insmed from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ28.22 B-12.6%
2025โ‚ฌ32.29 B169.85%
2024โ‚ฌ11.96 B198.4%
2023โ‚ฌ4.01 B58.93%
2022โ‚ฌ2.52 B-11.37%
2021โ‚ฌ2.84 B3.27%
2020โ‚ฌ2.75 B44.22%
2019โ‚ฌ1.91 B115.63%
2018โ‚ฌ0.88 B-55.45%
2017โ‚ฌ1.99 B155.73%
2016โ‚ฌ0.77 B-24.15%
2015โ‚ฌ1.02 B61.96%
2014โ‚ฌ0.63 B31.5%
2013โ‚ฌ0.48 B202.52%
2012โ‚ฌ0.15 B173.05%
2011โ‚ฌ58.32 M-21.44%
2010โ‚ฌ74.23 M6.08%
2009โ‚ฌ69.97 M71.09%
2008โ‚ฌ40.9 M-40.62%
2007โ‚ฌ68.87 M1.93%
2006โ‚ฌ67.57 M-38.92%
2005โ‚ฌ0.11 B52.02%
2004โ‚ฌ72.77 M-19.65%
2003โ‚ฌ90.57 M535.42%
2002โ‚ฌ14.25 M-89.99%
2001โ‚ฌ0.14 B17.94%
2000โ‚ฌ0.12 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Insmed was reported to be:

โ‚ฌ28.22 Billion
by Nasdaq info icon info icon
โ‚ฌ28.22 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
โ‚ฌ240.66 B 752.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
โ‚ฌ148.58 B 426.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚ฌ101.63 B 260.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚ฌ1.79 B-93.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
โ‚ฌ0.63 B-97.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
โ‚ฌ1.45 B-94.83%๐Ÿ‡บ๐Ÿ‡ธ USA